BIOY vs. QYLD

Last updated Jun 30, 2026

BIOY (GraniteShares YieldBOOST Biotech ETF) and QYLD (Global X NASDAQ 100 Covered Call ETF) are both exchange-traded funds - BIOY is a Derivative Income fund actively managed by GraniteShares, while QYLD is a Nasdaq-100 fund tracking the CBOE NASDAQ-100 Buy Write V2. BIOY is actively managed, while QYLD is passively managed. At a 0.15 correlation, their price movements are largely independent. BIOY charges 1.07%/yr vs 0.60%/yr for QYLD.

Performance

BIOY vs. QYLD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in GraniteShares YieldBOOST Biotech ETF (BIOY) and Global X NASDAQ 100 Covered Call ETF (QYLD). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

BIOY

• 1D: 0.04%
• 1M: 0.80%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

QYLD

• 1D: 2.13%
• 1M: 1.91%
• YTD: 9.63%
• 6M: 9.20%
• 1Y: 23.19%
• 3Y*: 14.01%
• 5Y*: 8.50%
• 10Y*: 9.96%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BIOY vs. QYLD - Yearly Performance Comparison

	2026 (YTD)
BIOY GraniteShares YieldBOOST Biotech ETF	0.69%
QYLD Global X NASDAQ 100 Covered Call ETF	3.27%

Correlation

The correlation between BIOY and QYLD is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (All Time) Calculated using the full available price history since May 5, 2026	0.15

Return for Risk

BIOY vs. QYLD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIOY

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

QYLD

QYLD Risk / Return Rank: 90
QYLD Sharpe Ratio Rank: 85
QYLD Sortino Ratio Rank: 86
QYLD Omega Ratio Rank: 92
QYLD Calmar Ratio Rank: 90
QYLD Martin Ratio Rank: 95

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BIOY vs. QYLD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for GraniteShares YieldBOOST Biotech ETF (BIOY) and Global X NASDAQ 100 Covered Call ETF (QYLD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BIOY	QYLD	Difference
Sharpe ratio: Return per unit of total volatility	—	2.34	—
Sortino ratio: Return per unit of downside risk	—	3.33	—
Omega ratio: Gain probability vs. loss probability	—	1.52	—
Calmar ratio: Return relative to maximum drawdown	—	4.69	—
Martin ratio: Return relative to average drawdown	—	25.14	—

Drawdowns

BIOY vs. QYLD - Drawdown Comparison

The maximum BIOY drawdown since its inception was -5.07%, smaller than the maximum QYLD drawdown of -24.75%. Use the drawdown chart below to compare losses from any high point for BIOY and QYLD.

Drawdown Indicators

	BIOY	QYLD	Difference
Max Drawdown Largest peak-to-trough decline	-5.07%	-24.75%	+19.68%
Max Drawdown (1Y) Largest decline over 1 year	—	-4.97%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-19.06%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-24.61%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-24.75%	—
Current Drawdown Current decline from peak	-0.76%	-0.52%	-0.24%
Average Drawdown Average peak-to-trough decline	-2.21%	-3.82%	+1.61%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	0.92%	—

Volatility

Volatility by Period

	BIOY	QYLD	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	5.29%	—
Volatility (6M) Calculated over the trailing 6-month period	—	8.74%	—
Volatility (1Y) Calculated over the trailing 1-year period	16.02%	9.97%	+6.05%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	16.02%	14.88%	+1.14%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	16.02%	15.55%	+0.47%

BIOY vs. QYLD - Expense Ratio Comparison

BIOY has a 1.07% expense ratio, which is higher than QYLD's 0.60% expense ratio.

Dividends

BIOY vs. QYLD - Dividend Comparison

BIOY's dividend yield for the trailing twelve months is around 9.48%, less than QYLD's 11.50% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BIOY GraniteShares YieldBOOST Biotech ETF	9.48%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
QYLD Global X NASDAQ 100 Covered Call ETF	11.50%	11.55%	12.50%	11.78%	13.75%	12.85%	11.16%	9.84%	12.44%	7.69%	9.15%	9.42%

Frequently Asked Questions

Can I hold both BIOY and QYLD in my portfolio?

BIOY and QYLD have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, BIOY or QYLD?

On fees, QYLD is cheaper at 0.60% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, BIOY or QYLD?

QYLD is cheaper with a 0.60% expense ratio, compared with 1.07% for BIOY.

Which ETF pays a higher dividend yield, BIOY or QYLD?

QYLD has the higher dividend yield at 11.50%, compared with 9.48% for BIOY.

What is the main difference between BIOY and QYLD?

BIOY is categorized as Derivative Income, while QYLD is Nasdaq-100. They also come from different issuers: GraniteShares and Global X. Their fees differ too: 1.07% for BIOY and 0.60% for QYLD.